Taribavirin

From WikiMD.org
Jump to navigation Jump to search

Taribavirin

Taribavirin (pronounced: tah-ri-ba-vi-rin) is an antiviral drug used in the treatment of Hepatitis C. It is a prodrug of ribavirin, which means it is metabolically converted into the active drug ribavirin in the body.

Etymology

The name "Taribavirin" is derived from the chemical structure of the drug. "Tari" is short for "taribavirin", which is a combination of parts of the words "ribavirin" and "tartrate". "Bavirin" is derived from "ribavirin", the active drug that taribavirin is converted into in the body.

Usage

Taribavirin is used in the treatment of chronic Hepatitis C, a viral infection that causes inflammation of the liver. It is often used in combination with other antiviral drugs, such as peginterferon alfa-2b or peginterferon alfa-2a, to increase the effectiveness of treatment.

Mechanism of Action

As a prodrug of ribavirin, taribavirin is metabolically converted into ribavirin in the body. Ribavirin then works by inhibiting the replication of the hepatitis C virus, thereby reducing the amount of virus in the body.

Related Terms

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski